SUPRIYA LIFESCIENCE LTD (SUPRIYA) financials — quarterly results, P&L, cash flow, balance sheet, shareholding
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.[1]
Supriya Lifescience Ltd
SUPRIYA
Market Cap₹6,777Cr.
Current Price₹842
High / Low₹1,086/546
Stock P/E32.4
Book Value₹149
Dividend Yield0.12%
ROCE25.1%
ROE19.1%
Face Value₹2.00
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic.[1]
Quarterly Results
Yearly Results
Shareholding Pattern
Shareholding Trend
Balance Sheet
Cash Flows
Last updated at: 24 July 2026 at 15:04:43